Causaly
PrivateLast Round
Series B
Jul 13, 2023
Total Funding Raised
$82.8M
Company Overview
Causaly is a biotechnology company that provides an AI-powered platform for life sciences and pharmaceutical research to accelerate drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, NLP & Conversational AI, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Causaly Comparables
Compare Causaly with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BenchSci | 89% | |
| Epistemic AI | 83% | |
| Biorelate | 80% |
Causaly Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 13, 2023 | ||||
| Series A Extension | May 19, 2021 | ||||
| Series A | Nov 19, 2019 | ||||
| Seed | Jul 26, 2018 |
Key People
Founding team and executive leadership
Causaly Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ICONIQ Growth | Series B |
| Visionaries Club | Series B |
| Marathon Venture Capital | Series A, Series A Extension, Series B, Seed |
| Emerge | Seed |
| European Bank for Reconstruction and Development | Series A, Series A Extension, Series B |
| Index Ventures | Series B, Series A Extension |
| Pentech | Series A Extension, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 8, 2026
Added L’Oréal Group as a customer.
- Mar 8, 2026
Added Lupin Pharmaceuticals as an enterprise customer.
Recent news
Latest coverage and updates
- integrates_withSep 17, 2026
Causaly integrates with Microsoft Corp..
- partners_withJul 29, 2026
Causaly partnered with Sage Pub on Jul 29th '26.
Causaly Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Causaly's valuation, stock price, and market status.
Is Causaly a public or private company?
Causaly is a private company.
What is the current stock price of Causaly?
Causaly is a private company with no public stock price. No recent secondary market data is available.
How much is Causaly worth (valuation)?
Valuation information for Causaly is not publicly available.
Can I buy Causaly stock?
Causaly shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Causaly's last funding round?
Causaly's most recent funding round was Series B on July 13, 2023.
Who are the main investors in Causaly?
Key investors in Causaly include ICONIQ Growth, Marathon Venture Capital, Index Ventures, Pentech, EBRD Venture Capital Investment Programme.
Will Causaly IPO soon?
No public IPO plans have been announced for Causaly.
How can I track Causaly secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Causaly's secondary market activity and sign up for updates.